Differential surface antigen expression and 1α,25-dihydroxyvitamin D₃ responsiveness distinguish human dermal fibroblasts with age-dependent osteogenic differentiation potential from marrow-derived stromal cells in vitro

References

• Bodine PVN, Komm BS. Tissue culture models for studies of hormone and vitamin action in bone cells. Vitam Horm. 2002; 64:101–51.
   PubMedGoogle Scholar
• Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morphol. 1966;16:381–90.
   PubMedGoogle Scholar
• Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guineapig bone marrow and spleen cells. Cell Tiss Kinet. 1970;3: 393–403.
   PubMedGoogle Scholar
• Pereira RF, Halford KW, O'Hara MD, Leeper DB, Sokolov BP, Pollard MD, . Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proc Nat Acad Sci USA. 1995;92:4857–61.
   PubMed Web of Science ®Google Scholar
• Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem. 1997;64:278–94.
   PubMed Web of Science ®Google Scholar
• Muschler GF, Boehm C, Easley K. Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume. J Bone Joint Surg. 1997;79A: 1699–709.
   Google Scholar
• Majors AK, Boehm CA, Nitto H, Midura RJ, Muschler GF. Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J Orthop Res. 1997;15: 546–57.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, . Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–7.
   PubMed Web of Science ®Google Scholar
• Colter DC, Class R, DiGirolamo CM, Prockop DJ. Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. PNAS. 2000;97: 3213–8.
   PubMed Web of Science ®Google Scholar
• Colter DC, Sekiya I, Prockop DJ. Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells. PNAS. 2001;98:7841–5.
   PubMed Web of Science ®Google Scholar
• Muschler GF, Nitto H, Boehm CA, Easley KA. Age- and gender-related changes in the cellularity of human bone marrow and the prevalence of osteoblastic progenitors. J Orthop Res. 2001;19:117–25.
   PubMed Web of Science ®Google Scholar
• Smith JR, Pochampally R, Perry A, Hsu S-C, Prockop DJ. Isolation of a highly clonogenic and multipotential subfraction of adult stem cells from bone marrow stroma. Stem Cells. 2004;22:823–31.
   PubMed Web of Science ®Google Scholar
• Akintoye SO, Lam T, Shi S, Brahim J, Collins MT, Robey PG. Skeletal site-specific characterization of orofacial and iliac crest human bone marrow stromal cells in same individuals. Bone. 2006;38:758–68.
   PubMed Web of Science ®Google Scholar
• Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, . Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211–28.
   PubMedGoogle Scholar
• Gimble JM, Guilak F. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy. 2003;5:362–9.
   PubMed Web of Science ®Google Scholar
• Guilak F, Lott KE, Awad HA, Cao Q, Hicok KC, Fermor B, . Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. J Cell Physiol. 2006;206: 229–37.
   PubMed Web of Science ®Google Scholar
• Lee JY, Qu-Petersen Z, Cao B, Kimura S, Jankowski R, Cummins J, . Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol. 2000;150:1085–100.
   PubMed Web of Science ®Google Scholar
• Deasy BM, Jankowski RJ, Huard J. Muscle-derived stem cells: characterization and potential for cell-mediated therapy. Blood Cells Mol Dis. 2001;27:924–33.
   PubMed Web of Science ®Google Scholar
• Young HE, Steele TA, Bray RA, Hudson J, Floyd JA, Hawkins K, . Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec. 2001;264:51–62.
   PubMedGoogle Scholar
• Toma JG, McKenzie IA, Bagli D, Miller FD. Isolation and characterization of multipotent skin-derived precursors from human skin. Stem Cells. 2005;23:727–37.
   PubMed Web of Science ®Google Scholar
• Bartsch G, Yoo JJ, DeCoppi P, Siddiqui MM, Schuch G, Pohl HG, . Propagation, expansion, and multilineage differentiation of human somatic stem cells from dermal progenitors. Stem Cells Dev. 2005;14:337–48.
   PubMed Web of Science ®Google Scholar
• Chen FG, Zhang WJ, Bi D, Liu W, Wei X, Chen FF, . Clonal analysis of nestin− vimentin+ multipotent fibroblasts isolated from human dermis. J Cell Sci. 2007;120:2875–83.
   PubMed Web of Science ®Google Scholar
• Lysy PA, Smets F, Sibille C, Najimi M, Sokal EM. Human skin fibroblasts: from mesodermal to hepatocyte-like differentiation. Hepatology. 2007;46:1574–85.
   PubMedGoogle Scholar
• Krebsbach PH, Gu K, Franceschi RT, Rutherford RB. Gene therapy-directed osteogenesis: BMP-7-transduced human fibroblasts form bone in vivo. Hum Gene Ther. 2000;11:1201–10.
   PubMed Web of Science ®Google Scholar
• Rutherford RB, Moalli M, Franceschi RT, Wang D, Gu K, Krebsbach PH. Bone morphogenetic protein-transduced human fibroblasts convert to osteoblasts and form bone in vivo. Tissue Eng. 2002;8:441–52.
   PubMedGoogle Scholar
• Phillips JE, Hutmacher DW, Guldberg RE, García AJ. Mineralization capacity of Runx2/Cbfa1-genetically engineered fibroblasts is scaffold dependent. Biomaterials. 2006;27:5535–45.
   PubMedGoogle Scholar
• Phillips JE, Guldberg RE, Garcia AJ. Dermal fibroblasts genetically modified to express Runx2/Cbfa1 as a mineralizing cell source for bone tissue engineering. Tissue Eng. 2007;13:2029–40.
   PubMedGoogle Scholar
• Hee CK, Jonikas MA, Nicoll SB. Influence of three-dimensional scaffold on the expression of osteogenic differentiation markers by human dermal fibroblasts. Biomaterials. 2006;27:875–84.
   PubMedGoogle Scholar
• Lorenz K, Sicker M, Schmelzer E, Rupf T, Salvetter J, Schulz-Siegmund M, . Multilineage differentiation potential of human dermal skin-derived fibroblasts. Exp Dermatol. 2008;17:925–32.
   PubMed Web of Science ®Google Scholar
• Takeda K, Gosiewska A, Peterkofsky B. Similar, but not identical, modulation of expression of extracellular matrix components during in vitro and in vivo aging of human skin fibroblasts. J Cell Physiol. 1992;153:450–9.
   PubMedGoogle Scholar
• Hee CK, Nicoll SB. Endogenous bone morphogenetic proteins mediate 1alpha,25-dihydroxyvitamin D3-induced expression of osteoblast differentiation markers in human dermal fibroblasts. J Orthop Res. 2008;27:162–8.
   Google Scholar
• Haynesworth S, Baber M, Caplan A. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone. 1992;13:69–80.
   PubMed Web of Science ®Google Scholar
• Bruder S, Horowitz M, Mosca J, Haynesworth S. Monoclonal antibodies reactive with human osteogenic cell surface antigens. Bone. 1997;21:225–35.
   PubMed Web of Science ®Google Scholar
• Young HE, Steele TA, Bray RA, Detmer K, Blake LW, Lucas PW, . Human pluripotent and progenitor cells display cell surface cluster differentiation markers CD10, CD13, CD56, and MHC class-I. Proc Soc Exp Biol Med. 1999;221:63–71.
   PubMed Web of Science ®Google Scholar
• Jones EA, Kinsey SE, English A, Jones RA, Straszynski L, Meredith DM, . Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells. Arth Rheum. 2002;46:3349–60.
   PubMed Web of Science ®Google Scholar
• De Ugarte DA, Alfonso Z, Zuk PA, Elbarbary A, Zhu M, Ashjian P, . Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunol Lett. 2003;89:267–70.
   PubMed Web of Science ®Google Scholar
• Stewart K, Monk P, Walsh S, Jefferiss C, Letchford J, Beresford J. STRO-1, HOP-26 (CD63), CD49a and SB-10 (CD-166) as markers of primitive human marrow stromal cells and their more differentiated progeny: a comparative investigation in vitro. Cell Tiss Res. 2003;313:281–90.
   PubMed Web of Science ®Google Scholar
• Jones EA, English A, Henshaw K, Kinsey SE, Markham AF, Emery P, . Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. Arth Rheum. 2004;50:817–27.
   PubMed Web of Science ®Google Scholar
• Ishii M, Koike C, Igarashi A, Yamanaka K, Pan H, Higashi Y, . Molecular markers distinguish bone marrow mesenchymal stem cells from fibroblasts. Biochem Biophys Res Comm. 2005;332:297–303.
   PubMed Web of Science ®Google Scholar
• Ndumbe PM, Levinsky RJ. Differences in surface antigen expression of human fibroblasts cultured from bone marrow compared with those obtained from skin and embryo lung tissue. Immunology. 1985;56:189–94.
   PubMedGoogle Scholar
• Vogel W, Grunebach F, Messam CA, Kanz L, Brugger W, Buhring H-J. Heterogeneity among human bone marrow-derived mesenchymal stem cells and neural progenitor cells. Haematologica. 2003;88:126–33.
   PubMed Web of Science ®Google Scholar
• Boonacker E, Van Noorden CJF. The multifunctional or moonlighting protein CD26/DPPIV. Eur J Cell Biol. 2003;82: 53–73.
   PubMed Web of Science ®Google Scholar
• Saison M, Verlinden J, Van Leuven F, Cassiman JJ, Van Den Bergher H. Identification of cell surface dipeptidylpeptidase IV in human fibroblasts. Biochem J. 1983;216:177–83.
   PubMedGoogle Scholar
• Raynaud F, Bauvois B, Gerbaud P, Evain-Brion D. Characterization of specific proteases associated with the surface of human skin fibroblasts, and their modulation in pathology. J Cell Physiol. 1992;151:378–85.
   PubMed Web of Science ®Google Scholar
• Sorrell JM, Brinon L, Baber MA, Caplan AI. Cytokines and glucocorticoids differentially regulate APN/CD13 and DPPIV/CD26 enzyme activities in cultured human dermal fibroblasts. Arch Dermatol Res. 2003;295(4):160–8.
   PubMedGoogle Scholar
• van Leeuwen JPTM, van Driel M, van den Bemd GJCM, Pols HAP. Vitamin D control of osteoblast function and bone extracellular matrix. Crit Rev Eukaryot Gene Expr. 2001;11: 199–226.
   PubMed Web of Science ®Google Scholar
• Owen TA, Aronow MS, Barone LM, Bettencourt B, Stein GS, Lian JB. Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology. 1991;128:1496–504.
   PubMed Web of Science ®Google Scholar
• Lian JB, Stein GS. The developmental stages of osteoblast growth and differentiation exhibit selective responses of genes to growth factors (TGFBeta1) and hormones (vitamin D and glucocorticoids). J Oral Implantol. 1993;19:95–105.
   PubMedGoogle Scholar
• Cheng S, Yang J, Rifas L, Zhang S, Avioli L. Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology. 1994;134:277–86.
   PubMed Web of Science ®Google Scholar
• Diefenderfer DL, Osyczka AM, Reilly GC, Leboy PS. BMP responsiveness in human mesenchymal stem cells. Connect Tiss Res. 2003;44:305–11.
   PubMed Web of Science ®Google Scholar
• Eijken M, Koedam M, van Driel M, Buurman CJ, Pols HAP, van Leeuwen JPTM. The essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralization. Mol Cell Endocrinol. 2006;248:87–93.
   PubMed Web of Science ®Google Scholar
• Sekiya I, Larson BL, Smith JR, Pochampally R, Cui J-G, Prockop DJ. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem Cells. 2002;20: 530–41.
   PubMed Web of Science ®Google Scholar
• Gordon KM, Duckett L, Daul B, Petrie HT. A simple method for detecting up to five immunofluorescent parameters together with DNA staining for cell cycle or viability on a benchtop flow cytometer. J Immunol Methods. 2003;275: 113–21.
   PubMedGoogle Scholar
• Singer VL, Jones LJ, Yue ST, Haugland RP. Characterization of PicoGreen reagent and development of a fluorescence-based solution assay for double-stranded DNA quantitation. Anal Biochem. 1997;249:228–38.
   PubMed Web of Science ®Google Scholar
• Sauer G, Wuthier R. Fourier transform infrared characterization of mineral phases formed during induction of mineralization by collagenase-released matrix vesicles in vitro. J Biol Chem. 1988;263:13718–24.
   PubMed Web of Science ®Google Scholar
• Moriguchi T, Yano K, Nakagawa S, Kaji F. Elucidation of adsorption mechanism of bone-staining agent alizarin red S on hydroxyapatite by FT-IR microspectroscopy. J Colloid Interface Sci. 2003;260:19–25.
   PubMed Web of Science ®Google Scholar
• Hee CK, Jonikas MA, Nicoll SB. Induction of osteogenic differentiation in human dermal fibroblasts in the presence of 1alpha,25-dihydroxyvitamin D3. Trans Orthopaed Res Soc. 2004;29:380.
   Google Scholar
• Bernardo ME, Zaffaroni N, Novara F, Cometa AM, Avanzini MA, Moretta A, . Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res. 2007;67:9142–9.
   PubMed Web of Science ®Google Scholar
• Dimitriou H, Linardakis E, Martimianaki G, Stiakaki E, Perdikogianni C, Charbord P, . Properties and potential of bone marrow mesenchymal stromal cells from children with hematologic diseases. Cytotherapy. 2008;10:125–33.
   PubMed Web of Science ®Google Scholar
• Choumerianou DM, Dimitriou H, Perdikogianni C, Martimianaki G, Riminucci M, Kalmanti M. Study of oncogenic transformation in ex vivo expanded mesenchymal cells, from paediatric bone marrow. Cell Proliferation. 2008;41: 909–22.
   PubMed Web of Science ®Google Scholar
• Dimitriou H, Perdikogianni C, Martimianaki G, Choumerianou DM, Pelagiadis J, Kalmanti M. Are mesenchymal stromal cells from children resistant to apoptosis? Cell Proliferation. 2009;42:276–83.
   PubMedGoogle Scholar
• Zhang Z-Y, Teoh S-H, Chong MSK, Schantz JT, Fisk NM, Choolani MA, . Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells. Stem Cells. 2009;27:126–37.
   PubMed Web of Science ®Google Scholar
• Brenner KA, Corbett SA, Schwarzbauer JE. Regulation of fibronectin matrix assembly by activated Ras in transformed cells. Oncogene. 2000;19:3156–63.
   PubMed Web of Science ®Google Scholar
• Rowlands AS, George PA, Cooper-White JJ. Directing osteogenic and myogenic differentiation of MSCs: interplay of stiffness and adhesive ligand presentation. Am J Physiol Cell Physiol. 2008;295:C1037–44.
   PubMed Web of Science ®Google Scholar
• Dumas M, Chaudagne C, Bonte F, Meybeck A. In vitro biosynthesis of type I and III collagens by human dermal fibroblasts from donors of increasing age. Mech Ageing Dev. 1994;73:179–87.
   Google Scholar
• Khorramizadeh MR, Tredget EE, Telasky C, Shen Q, Ghahary A. Aging differentially modulates the expression of collagen and collagenase in dermal fibroblasts. Mol Cell Biochem. 1999;194:99–108.
   PubMed Web of Science ®Google Scholar
• Sethe S, Scutt A, Stolzing A. Aging of mesenchymal stem cells. Ageing Res Rev. 2006;5:91–116.
   PubMed Web of Science ®Google Scholar
• Stolzing A, Scutt A. Age-related impairment of mesenchymal progenitor cell function. Aging Cell. 2006;5:213–24.
   PubMed Web of Science ®Google Scholar
• Kveiborg M, Rattan SIS, Clark BFC, Eriksen EF, Kassem M. Treatment with 1,25-dihydroxyvitamin D3 reduces impairment of human osteoblast functions during cellular aging in culture. J Cell Physiol. 2001;186:298–306.
   PubMedGoogle Scholar
• Martinez ME, Medina S, Sanchez M, Del Campo MT, Esbrit P, Rodrigo A, . Influence of skeletal site of origin and donor age on 1,25(OH)2D3-induced response of various osteoblastic markers in human osteoblastic cells. Bone. 1999; 24:203–9.
   PubMedGoogle Scholar
• Theobold VA, Lauer JD, Kaplan FA, Baker KB, Rosenberg M. ‘Neutral allografts’: lack of allogeneic stimulation by cultured human cells expressing MHC class I and class II antigens. Transplantation. 1993;55:128–33.
   PubMedGoogle Scholar
• Eaglstein WH, Iriondo M, Laszlo K. A composite skin substitute (graftskin) for surgical wounds. A clinical experience. Dermatol Surg. 1995;21:839–43.
   PubMed Web of Science ®Google Scholar
• Phillips TJ. New skin for old: developments in biological skin substitutes. Arch Dermatol. 1998;134:344–9.
   PubMedGoogle Scholar
• Nemecek GM, Dayan AD. Safety evaluation of human living skin equivalents. Toxicol Pathol. 1999;27:101–3.
   PubMedGoogle Scholar
• Lennon DP, Haynesworth SE, Arm DM, Baber MA, Caplan AI. Dilution of mesenchymal stem cells with dermal fibroblasts and the effects on in vitro and in vivo osteochondrogenesis. Dev Dyn. 2000;219:50–62.
   PubMed Web of Science ®Google Scholar